Received Mar 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
A patient received the first Shingrix dose on 7/27/2021 and never received his second dose; This non-serious case was reported by a other health professional via call center representative and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (1st dose received on 27-JUL-2021). On an unknown date, the patient did not received the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: A patient received the first Shingrix dose on 7/27/2021 and never received his second dose). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK Receipt Date: 22-FEB-2025 and 24-FEB-2025 A patient received the first Shingrix dose on 27-JUL-2021 and never received his second dose. If he were to get one now would he have to start the series over or would this count as his second dose. The Vaccine Administration Facility is the same as Primary Reporter. Till the time of reporting, the patient did not receive the 2nd dose, which led to incomplete course of vaccination.